Evidence map›Paper›PMID 16539040›Full record

ArticleThe Journal of parasitology2005

Molecular characterization of a human BRCA2 homolog in Leishmania donovani.

Smita Misra, Mack Hall, Gautam Chaudhuri

Abstract read
In one paragraph

Article in The Journal of parasitology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Smita MisraDivision of Microbial Pathogenesis & Immune Response, Department of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208, USA.
Mack Hall
Gautam Chaudhuri
Meharry Medical College · USAssociated Press · US

Funding

THE MOLECULAR BASIS OF BARTONELLA BACILLIFORMIS PATHOGENICITYS06GM008037 · NIGMS · MEHARRY MEDICAL COLLEGE · PI RUCKER, HUBERT K. · 1989 to 2007
$17.5M
DNA ANTISENSE APPROACH AGAINST LEISHMANIASISR01AI042327 · NIAID · MEHARRY MEDICAL COLLEGE · PI CHAUDHURI, GAUTAM · 1998 to 2000
$217k
NIAID NIH HHS 5R01AI42327-03NIAID NIH HHS R01 AI042327NIGMS NIH HHS 3 S06 GM008037-33S1NIGMS NIH HHS S06 GM008037
6 · The paper itself

Abstract

The breast cancer susceptibility protein BRCA2 is implicated in the DNA double-strand break (DSB) repair pathway through its association with Rad51. It is almost a ubiquitous eukaryotic protein; homologs of the BRCA2 gene (BRH2) have been identified in many mammals, as well as nonmammals. As a part of our quest to understand the DNA damage, repair, and recombination process in the parasitic protozoan, Leishmania sp., we have cloned and characterized a BRCA2 homolog from Leishmania sp. (LBRH2). LBRH2 is coded by a single-copy gene (ORF = 3,498 bp) located at the 700-kb chromosome 16. The transcripts in both the promastigotes and the amastigotes are approximately 3.9 kilonucleotides (knt) in size, corresponding to a protein with a calculated molecular mass of 128 kDa. The primary transcript of the gene is alternatively trans-spliced to produce 3 distinct mRNAs with altered folded structures at their 5' ends. This study will contribute toward the understanding of a potential RAD51-mediated DNA recombination/repair pathway in Leishmania sp.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsBase SequenceBlotting, NorthernBlotting, SouthernBRCA2 ProteinCloning, MolecularDensitometryDNA RepairElectrophoresis, Gel, Pulsed-FieldLeishmania donovaniMolecular Sequence DataOpen Reading FramesRad51 RecombinaseRNA, MessengerBRCA2 ProteinRad51 RecombinaseRNA, MessengerUntranslated Regions

Identifiers

PMID16539040
PMCPMC3075859
OpenAlexW2145248841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.